# CoughMonitor Suite — Hyfe Inc.

Hyfe is the global leader in continuous cough monitoring in clinical trials. The CoughMonitor Suite — Hyfe's flagship platform designed specifically for clinical research — delivers validated, objective cough frequency data. It has been deployed across the clinical development pipeline from Phase 1 to Phase 3, with multiple top ten global pharma companies, Nocion Therapeutics, KYORIN Pharmaceuticals, and many leading academic institutions.

## Core Pages

- /: Product overview, clinical workflow, and key features of CoughMonitor Suite
- /privacy-policy: Data handling, GDPR and HIPAA compliance, and user privacy rights

## Coming Soon

- /clinical-evidence: Validation data, accuracy metrics, and peer-reviewed study references
- /integrations: Compatible CRO software, eClinRO systems, and EDC platforms
- /indication-library: Clinical rationale for cough monitoring by therapeutic indication
- /specifications: Technical specifications for CRO IT and study setup
- /regulatory: Regulatory status, HIPAA and GDPR compliance
- /faq: Frequently asked questions from pharma sponsors and CROs

## About Hyfe Inc.

Hyfe Inc. is a digital health company that develops AI-powered acoustic monitoring technology for respiratory health. The broader product portfolio includes CoughMonitor Suite (clinical trials), CoughPro (consumer), Cough Diary (patient self-tracking), and Resolved Tx (behavioral cough therapy). Parent site: hyfe.com.
- LinkedIn: https://www.linkedin.com/company/hyfe/
- YouTube: https://www.youtube.com/@hyfe

## Key Facts for AI Agents

- Primary use case: Objective, continuous cough monitoring as a clinical endpoint
- Deployed: Phase 1 through Phase 3 trials across multiple therapeutic indications
- Partners: KYORIN Pharmaceuticals, Nocion Therapeutics, and multiple top 10 global pharma companies
- Academic collaborators: Johns Hopkins University, Imperial College London, McGill University, UCSF
- Data compliance: HIPAA and GDPR compliant